ACT-333679
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ACT-333679, covering 2014-08-01 to 2014-08-01. Get the full timeline:
Most recent: Clinical Trial Update: Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects [Phase 1]